{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:49:45Z","timestamp":1790704185509,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013213","name":"Arup Institute for Clinical and Experimental Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.pathol.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T11:59:56Z","timestamp":1614945596000},"page":"312-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-7847","authenticated-orcid":false,"given":"Tracy I.","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bajel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.02.001_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib2","year":"2017"},{"key":"10.1016\/j.pathol.2021.02.001_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5858\/arpa.2016-0504-CP","article-title":"Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology","volume":"141","author":"Arber","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2021.02.001_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/10428194.2015.1115041","article-title":"Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults","volume":"57","author":"Babushok","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.02.001_bib5","first-page":"58","article-title":"Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies","volume":"89","author":"Bueno","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00000478-200207000-00003","article-title":"'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.2830470406","article-title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma","volume":"47","author":"Adachi","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib8","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"214","article-title":"Blastic NK-cell lymphoma","author":"Chan","year":"2001"},{"key":"10.1016\/j.pathol.2021.02.001_bib9","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/1097-0142(19950515)75:10<2474::AID-CNCR2820751013>3.0.CO;2-Y","article-title":"Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in\u00a0vitro culture with inducing agents","volume":"75","author":"Brody","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2021.02.001_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jegalian","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib13","first-page":"161","article-title":"Skin manifestations in CD4+, CD56+ malignancies","volume":"13","author":"Penven","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.pathol.2021.02.001_bib14","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib16","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","article-title":"CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique","volume":"99","author":"Leroux","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2010.08556.x","article-title":"TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm","volume":"153","author":"Jardin","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.02.001_bib19","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"137","article-title":"Acute myeloid leukaemia with recurrent genetic abnormalities","author":"Arber","year":"2017"},{"key":"10.1016\/j.pathol.2021.02.001_bib20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.leu.2404233","article-title":"A\u00a0retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies","volume":"20","author":"Slovak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ijlh.12641","article-title":"Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34)","volume":"39","author":"Visconte","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib23","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/sj.onc.1205315","article-title":"Transcription factor fusions in acute leukemia: variations on a theme","volume":"21","author":"Scandura","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2021.02.001_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cancergencyto.2010.08.012","article-title":"The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases","volume":"203","author":"Gupta","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2021.02.001_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/bjh.16433","article-title":"Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission","volume":"189","author":"Diaz-Beya","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.5858\/arpa.2016-0059-RA","article-title":"The new clinicopathologic and molecular findings in myeloid neoplasms with inv(3)(q21q26)\/t(3;3)(q21;q26)","volume":"140","author":"Wang","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2021.02.001_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","article-title":"A\u00a0single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia","volume":"157","author":"Groschel","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2021.02.001_bib28","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib29","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.1993.tb04647.x","article-title":"Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3","volume":"83","author":"Grigg","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2141.1995.tb05329.x","article-title":"Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom cancer cytogenetic group study","volume":"91","author":"Secker-Walker","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood.V66.6.1362.1362","article-title":"Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia","volume":"66","author":"Bitter","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-4608(96)00293-2","article-title":"Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies","volume":"96","author":"Shi","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2021.02.001_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.leukres.2009.08.029","article-title":"Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)\/t(3;3)(q21;q26.2)","volume":"34","author":"Medeiros","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.pathol.2021.02.001_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1179\/1607845415Y.0000000003","article-title":"Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3","volume":"20","author":"Raya","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.pathol.2021.02.001_bib36","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"30","article-title":"Chronic myeloid leukaemia, BCR-ABL1-positive","author":"Vardiman","year":"2017"},{"key":"10.1016\/j.pathol.2021.02.001_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2014-07-591461","article-title":"Mutational spectrum of myeloid malignancies with inv(3)\/t(3;3) reveals a predominant involvement of RAS\/RTK signaling pathways","volume":"125","author":"Groschel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3324\/haematol.2013.096420","article-title":"Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)\/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study","volume":"99","author":"Rogers","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib39","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1080\/10428190701632848","article-title":"Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)\/t(3;3) (q21;q26) positive AML","volume":"48","author":"Weisser","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.02.001_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1309\/AJCP48AJDCKTHUXC","article-title":"Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia","volume":"136","author":"Cui","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41409-018-0165-x","article-title":"AlloHSCT for inv(3)(q21;q26)\/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European Society for Blood and Marrow Transplantation","volume":"53","author":"Halaburda","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pathol.2021.02.001_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2012.701739","article-title":"Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia","volume":"54","author":"Konoplev","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.02.001_bib43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1309\/B4NVER1AJJ84CTUU","article-title":"Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis","volume":"127","author":"Soupir","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib44","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.leu.2401229","article-title":"Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience","volume":"12","author":"Paietta","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib45","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bjh.12301","article-title":"Does BCR\/ABL1 positive acute myeloid leukaemia exist?","volume":"161","author":"Nacheva","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.leu.2404981","article-title":"Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia","volume":"22","author":"Quintas-Cardama","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib48","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/bloodadvances.2018015594","article-title":"BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease?","volume":"2","author":"Neuendorff","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.02.001_bib49","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"180","article-title":"Acute leukaemias of ambiguous lineage","author":"Borowitz","year":"2017"},{"key":"10.1016\/j.pathol.2021.02.001_bib50","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/sj.leu.2404848","article-title":"Acute bilineal leukemia: a rare disease with poor outcome","volume":"21","author":"Weir","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib51","first-page":"64","article-title":"Definition of acute biphenotypic leukemia","volume":"82","author":"Matutes","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib52","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.leukres.2015.03.012","article-title":"Survival of patients with mixed phenotype acute leukemias: a large population-based study","volume":"39","author":"Shi","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.pathol.2021.02.001_bib53","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib54","doi-asserted-by":"crossref","first-page":"106301","DOI":"10.1016\/j.leukres.2020.106301","article-title":"Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database","volume":"89","author":"Qasrawi","year":"2020","journal-title":"Leuk Res"},{"key":"10.1016\/j.pathol.2021.02.001_bib55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1097-0142(19920115)69:2<396::AID-CNCR2820690220>3.0.CO;2-E","article-title":"Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features","volume":"69","author":"Bassan","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2021.02.001_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2009.08058.x","article-title":"Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations","volume":"149","author":"Gerr","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib57","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V92.2.596","article-title":"The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL)","volume":"92","author":"Bene","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.semdp.2011.08.004","article-title":"Acute leukemias of ambiguous lineage","volume":"29","author":"Bene","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1309\/AJCPPVUPOTUVOIB5","article-title":"Mixed phenotype acute leukemia: a study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria","volume":"142","author":"Weinberg","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-4608(96)00127-6","article-title":"Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases","volume":"92","author":"Cuneo","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2021.02.001_bib62","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00277-013-1694-4","article-title":"Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization","volume":"92","author":"Heesch","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib63","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41379-019-0263-3","article-title":"Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group","volume":"32","author":"Weinberg","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib64","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib65","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12185-011-0953-1","article-title":"Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and\/or bcr-abl positive in adult","volume":"94","author":"Wang","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2021.02.001_bib67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.12484","article-title":"Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview","volume":"163","author":"Manola","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","article-title":"CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia","volume":"137","author":"Hoehn","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib69","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.02.001_bib70","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.1998.00523.x","article-title":"Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression","volume":"100","author":"Legrand","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib71","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbmt.2016.02.013","article-title":"Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia","volume":"22","author":"Munker","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pathol.2021.02.001_bib72","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib73","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2002-04-1010","article-title":"Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome\/acute myeloid leukemia","volume":"101","author":"Harada","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib74","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib75","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/leu.2009.210","article-title":"Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD\/AML syndrome","volume":"24","author":"Jongmans","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib77","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1182\/blood-2009-11-255976","article-title":"RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis","volume":"117","author":"Schnittger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib78","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1182\/blood-2009-05-223784","article-title":"AML1\/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations","volume":"114","author":"Tang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib79","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V96.9.3154","article-title":"Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis","volume":"96","author":"Imai","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib80","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/leu.2016.207","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib81","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2007-02-072595","article-title":"Trisomy 13 is strongly associated with AML1\/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia","volume":"110","author":"Dicker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib82","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s41379-020-0531-2","article-title":"Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1","volume":"33","author":"Quesada","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib83","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1042819031000139611","article-title":"Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia","volume":"45","author":"Ganly","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.02.001_bib85","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3324\/haematol.2014.114157","article-title":"ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group","volume":"100","author":"Paschka","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.02.001_bib86","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"156","article-title":"Acute myeloid leukaemia, NOS","author":"Arber","year":"2017"},{"key":"10.1016\/j.pathol.2021.02.001_bib87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajcp\/98.1.34","article-title":"The prognostic significance of proerythroblasts in acute erythroleukemia","volume":"98","author":"Kowal-Vern","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib88","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib89","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/AJCP8M4QQTAZPGRP","article-title":"E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms","volume":"141","author":"Ohgami","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2021.02.001_bib91","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1182\/bloodadvances.2020002712","article-title":"Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group","volume":"4","author":"Chisholm","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.02.001_bib92","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood-2016-11-749903","article-title":"More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia","volume":"129","author":"Montalban-Bravo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.02.001_bib93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/modpathol.3800348","article-title":"Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia","volume":"18","author":"Orazi","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00277-004-0881-8","article-title":"Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up","volume":"83","author":"Thiele","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib95","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1038\/s41375-019-0523-8","article-title":"TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis","volume":"33","author":"Pantic","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib96","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1080\/10428190410001683688","article-title":"Acute panmyelosis with myelofibrosis: clinical, immunophenotypic and cytogenetic study of twelve cases","volume":"45","author":"Suvajdzic","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.02.001_bib97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0609.2001.t01-1-00487.x","article-title":"Acute basophilic leukemia","volume":"67","author":"Giagounidis","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2021.02.001_bib98","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/leu.2017.15","article-title":"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders","volume":"31","author":"Valent","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.02.001_bib99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-4608(88)90193-8","article-title":"Translocation (3;6)(q21;p21) in acute myeloid leukemia with abnormal thrombopoiesis and basophilia","volume":"30","author":"Hoyle","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2021.02.001_bib100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/jcp.42.8.785","article-title":"Basophils in acute myeloid leukaemia","volume":"42","author":"Hoyle","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.02.001_bib101","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1182\/blood-2011-01-333013","article-title":"Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants","volume":"117","author":"Quelen","year":"2011","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:26:56Z","timestamp":1758472016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0031302521000544"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.02.001","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}